Soligenix Announces Positive Top-line Results for its Pivotal Ph
SNGX: Soligenix, Inc.
2020-03-19 06:00:00
Soligenix Announces Positive Top-line Results for its Pivotal Phase 3 FLASH Trial Evaluating SGX301 in Treatment of Cutaneous T-Cell Lymphoma
2020-03-19 06:00:00
Soligenix Announces Positive Top-line Results for its Pivotal Phase 3 FLASH Trial Evaluating SGX301 in Treatment of Cutaneous T-Cell Lymphoma